p53 enhances ascorbyl stearate-induced G2/M arrest of human ovarian cancer cells

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 3927-3934

  Naidu, K Akhilender ^a,d,e   Fang, Quan ^b,e   Naidu, Kamatham A ^c   Cheng, Jin Q ^a,b   Nicosia, Santo V ^a,b   Coppola, Domenico ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Ascorbyl stearate; Cell cycle; G2 M arrest; Ovarian carcinoma

Indexed keywords

ASCORBYL STEARATE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN P21; PROTEIN P53; TYROSINE;

ARTICLE; CANCER CELL; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DNA REPAIR; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ASCORBIC ACID; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; G2 PHASE; HUMANS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 37549057562     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Xu J, Smigal C and Thun MJ: Cancer Statistics, 2006. CA Cancer J Clic 56: 106-130, 2006.
2. Nen RB and Cottreau C: Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91: 1459-1467, 1999.
3. Liehr JG: Vitamin C reduces the incidence and severity of renal tumors induced by estradiol or diethylstilbestrol. Am J Clin Nutr 54: 1256S-1260S, 1991.
4. Ibric LL, Peterson AR and Sevanian A: Mechanisms of ascorbic acid-induced inhibition of chemical transformation in C3H/10T1/2 cells. Am J Clin Nutr 54: 1236S-1240S, 1991.
5. Aidoo A, Lyn-Cook LE, Lensing S and Warner W: Ascorbic acid (vitamin C) modulates the mutagenic effects produced by an alkylating agent in vivo. Environ Mol Mutagen 24: 220-228, 1994.
6. Banks WA and Kastin AJ: Peptides and blood brain barrier: lipophilicity as predictor of permeability. Brain Res Bull 15: 287 292, 1985.
7. Naidu AK, Wiranowska M, Kori SH, Prockop LD and Kulkarni AP: Inhibition of human glioma cell proliferation and glutathione-S-transferase by ascorbyl esters and interferon. Anticancer Res 13: 1469-1471, 1993.
8. MakinoY, Sakagami H and Takeda M: Induction of cell death by ascorbic acid derivatives in human renal carcinoma and glioblastoma cell line. Anticancer Res 19: 3125-3132, 1999 .
9. Liu JW, Nago N, Kageyama K and Miwa N: Anti-metastatic effect of an autooxidation-resistant and lipophilic ascorbic acid derivative through inhibition of tumor invasion. Anticancer Res 20: 113 118, 2000.
10. Naidu AK, Wiranowska M, Kori SH, Prockop LD and Kulkarni AP: Inhibition of cell proliferation and glutathione-S-transferase by ascorbyl esters and interferon in mouse glioma. J Neuro-Oncol 16: 1-10, 1993.
11. Naidu KA, Tang JL, Naidu KA, Prockop LD, Nicosia SV and Coppola D: Antiproliferative and apoptotic effect of ascorbyl stearate in human glioblastoma multiforme cell: Modulation of insulin-like growth factor-I receptor (IGF-IR) expression. J Neuro-Oncol 54: 15-22, 2001.
12. Fang Q, Naidu KA, Naidu KA Zhao H, Sun M, Dan HC, Nasir A, Kaiser HE, Cheng JQ, Nicosia SV and Coppola D: Ascorbyl stearate inhibits cell proliferation and tumor growth in human ovarian carcinoma cells by targeting the P12K/AKT pathway. Anticancer Res 26: 203-209, 2006.
13. Cox LS and Lane DP: Tumor suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage. BioEssays 17: 501-508, 1995.
14. Ko LJ and Prives C: p53: puzzle and paradigm. Genes Dev 10: 1054-1072, 1996.
15. Levine AJ: P53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
16. Denhardt DT: Signal transduction pathways and regulation of the mammalian cell cycle: cell type-dependent integration of external signals. In: The Molecular Basis of Cell Cycle and Growth Control. Stein G, Baserga R, Giordano A and Denhardt David T (eds.). New York, Wiley-Liss, pp. 225-304, 1999.
17. Brummelkamp TR, Bernards R and Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 296(5567): 550-553, 2002.
18. Tsao CS: Inhibiting effect of ascorbic acid on growth of human mammary tumor xenografts. Am J Clin Nutr 54: 1274S-1280S.
19. Liehr JG: Vitamin C reduces the incidence and severity of renal tumors induced by estradiol or diethylstibesterol. Am J Clin Nutr 54: 1256S-1260S, 1991.
20. Park CH and Kimler BF: Growth modulation of human leukemic, pre-leukemic and myeloma progenitor cell by L-ascorbic acid. Am J Clin Nutr 54: 1241S-1246S, 1991.
21. Eckert-Maksic M, Kovacek I, Maksic ZB, Osmak M and Paveli K: Effect of ascorbic acid and its derivatives on different tumors in vivo and in vitro. In: Molecules in Natural Science and Medicine. An Encomium for Linus Pauling. Maksic ZB and Eckert-Maksic M (eds.). New York: Ellis Horwood, pp. 509 524, 1991.
22. Murakami K, Muto N, Fukasawa GK and Yamamoto I: Comparison of ascorbic acid and ascorbic acid 2-O-L-glucosidase on the cytotoxicity and bioavailability to low density culture of fibroblast. Biochem Pharmacol 44: 2191-2197, 1992.
23. Roomi MW, House D, Eckert-Maksic M, Maksic ZB and Tsao CS: Growth suppression of malignant leukemia cell line in vitro by ascorbic acid (Vitamin C) and its derivatives. Cancer Lett 122: 93-99, 1998.
24. Pavelic K: L-ascorbic acid induced DNA strand breaks and cross links in human neuroblastoma cell. Brain Res 342: 369-373, 1985.
25. Medina MA, de Veas RG and Schweigerer L: Ascorbic acid is cytotoxic for pediatric tumor cells cultured in vitro. Biochem Mol Biol Inter 34: 871-874, 1994.
26. Roomi MW, House D and Tsao CS: Cytotoxic effect of substitution at 2-, 6-, and 2,6-positions in ascorbic acid on malignant cell line. Cancer Biochem Biophys 16: 295-300, 1998.
27. Naidu KA, Karl RC, Naidu KA and Coppola D: Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor. Dig Dis Sci 48(1): 230-237, 2003.
28. Nurse P: Universal control mechanism regulating onset of M-phase. Nature 344(6266): 503-508, 1990.
29. Pines J: Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 308(Pt 3): 697-711, 1995.
30. Booher RN, Holman PS and Fattaey A: Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J Biol Chem 272(35): 22300-22306, 1997.
31. Taylor WR and Stark GR: Regulation of the G2/M transition by p53. Oncogene 20(15): 1803-1815, 2001.
32. Walker DH, DePaoli-Roach AA and Mailer JL: Multiple roles for protein phosphatase 1 in regulating the Xenopus early embryonic cell cycle. Mol Cell Biol 3: 687-698, 1992.